BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1264)

  • 1. Spin-labelled phosphofructokinase. A simple and direct approach to the study of allosteric equilibria under near-physiological conditions.
    Jones R; Dwek RA; Walker IO
    Eur J Biochem; 1975 Dec; 60(1):187-98. PubMed ID: 1264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetics of effector binding to phosphofructokinase. The influence of effectors on the allosteric conformational transition.
    Roberts D; Kellett GL
    Biochem J; 1980 Sep; 189(3):569-79. PubMed ID: 6260084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An equilibrium binding study of the interaction of fructose 6-phosphate and fructose 1,6-bisphosphate with rabbit muscle phosphofructokinase.
    Hill DE; Hammes GG
    Biochemistry; 1975 Jan; 14(2):203-13. PubMed ID: 123467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of substrates and effectors on the reversible inactivation of pig spleen phosphofructokinase by adenosine triphosphate.
    Weidemann MJ; Kolbuch-Braddon ME; Hickman PE
    Biochem J; 1977 Sep; 165(3):525-37. PubMed ID: 21659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of inhibitors with muscle phosphofructokinase.
    Colombo G; Tate PW; Girotti AW; Kemp RG
    J Biol Chem; 1975 Dec; 250(24):9404-12. PubMed ID: 127795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational states of rabbit muscle phosphofructokinase investigated by a spin label probe.
    Jones R; Dwek RA; Walker IO
    FEBS Lett; 1972 Oct; 26(1):92-6. PubMed ID: 4344298
    [No Abstract]   [Full Text] [Related]  

  • 7. Spectroscopic studies on effector-induced and substrate-induced conformation changes of phosphofructokinase.
    Grosse R; Eckert K; Otto M; Jacobasch G; Repke KR
    Eur J Biochem; 1977 Apr; 74(3):509-19. PubMed ID: 140049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of calmodulin with muscle phosphofructokinase. Interplay with metabolic effectors of the enzyme under physiological conditions.
    Mayr GW
    Eur J Biochem; 1984 Sep; 143(3):521-9. PubMed ID: 6236976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of muscle phosphofructokinase at physiological concentration of enzyme.
    Boscá L; Aragón JJ; Sols A
    J Biol Chem; 1985 Feb; 260(4):2100-7. PubMed ID: 2982809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric properties of muscle phosphofructokinase. 3. Thiol reactivity as an indicator of conformational state.
    Mathias MM; Kemp RG
    Biochemistry; 1972 Feb; 11(4):578-84. PubMed ID: 4334906
    [No Abstract]   [Full Text] [Related]  

  • 11. Phosphofructokinase. II. Role of ligands in pH-dependent structural changes of the rabbit muscle enzyme.
    Bock PE; Frieden C
    J Biol Chem; 1976 Sep; 251(18):5637-43. PubMed ID: 9394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and properties of adductor muscle phosphofructokinase from the oyster, Crassostrea virginica. The aerobic/anaerobic transition: role of arginine phosphate in enzyme control.
    Storey KB
    Eur J Biochem; 1976 Nov; 70(2):331-7. PubMed ID: 12948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of muscle phosphofructokinase by alpha-glucose 1,6-bisphosphate and fructose 2,6-bisphosphate is differently affected by other allosteric effectors and by pH.
    Andrés V; Carreras J; Cussó R
    Biochem Biophys Res Commun; 1988 Dec; 157(2):664-9. PubMed ID: 2974284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific modification of an effector binding site of phosphofructokinase by pyridoxal phasphate.
    Colombo G; Kemp RG
    Biochemistry; 1976 Apr; 15(8):1774-80. PubMed ID: 178355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spin-labelled phosphofructokinase and its interactions with ATP and metal-ATP complexes as studied by magnetic-resonance methods.
    Jones R; Dwek RA; Walker IO
    Eur J Biochem; 1973 Apr; 34(1):28-40. PubMed ID: 4349656
    [No Abstract]   [Full Text] [Related]  

  • 16. Substrate- and effector-induced conformational changes in phosphofructokinase from white muscle of rainbow trout (Oncorhynchus mykiss): a fluorescence study.
    Su JY; Storey KB
    Biochem Cell Biol; 1993; 71(5-6):255-9. PubMed ID: 8274266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific, reversible inactivation of phosphofructokinase by fructose-1,6-bisphosphatase. Involvement of adenosine 5'-triphosphate, oleate, and 3-phosphoglycerate.
    Proffitt RT; Sankaran L
    Biochemistry; 1976 Jun; 15(13):2918-25. PubMed ID: 181051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart phosphofructokinase: allosteric kinetics with fructose 6-sulfate.
    Martensen TM; Mansour TE
    Biochemistry; 1976 Nov; 15(23):4973-80. PubMed ID: 136271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphofructokinase control in muscle: nature and reversal of pH-dependent ATP inhibition.
    Dobson GP; Yamamoto E; Hochachka PW
    Am J Physiol; 1986 Jan; 250(1 Pt 2):R71-6. PubMed ID: 2934994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinetics of effector binding to phosphofructokinase. The allosteric conformational transition induced by 1,N6-ethenoadenosine triphosphate.
    Roberts D; Kellett GL
    Biochem J; 1979 Nov; 183(2):349-60. PubMed ID: 160791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.